Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diabetes, hypertension and hyperlipidaemia

P N Durrington1

  • 1Department of Medicine, Manchester Royal Infirmary, UK.

Postgraduate Medical Journal
|January 1, 1993
PubMed
Summary

Diabetic patients with high cholesterol face coronary heart disease risks due to elevated lipoproteins. Effective management involves weight reduction, lipid-lowering drugs like fibrates, and careful selection of antihypertensives to avoid adverse lipid profile changes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardiovascular disease morbidity is associated with social deprivation in subjects with familial hypercholesterolaemia (FH): A retrospective cohort study of individuals with FH in UK primary care and the UK Simon Broome register, linked with national hospital records.

Atherosclerosis·2025
Same author

Coronary heart disease mortality in treated familial hypercholesterolaemia: Update of the UK Simon Broome FH register.

Atherosclerosis·2018
Same author

Prescribing high-dose lipid-lowering therapy early to avoid subsequent cardiovascular events: is this a cost-effective strategy?

European journal of preventive cardiology·2011
Same author

Protection Against Nephropathy in Diabetes with Atorvastatin (PANDA): a randomized double-blind placebo-controlled trial of high- vs. low-dose atorvastatin(1).

Diabetic medicine : a journal of the British Diabetic Association·2010
Same author

All-cause and cardiovascular mortality in treated patients with severe hypertriglyceridaemia: A long-term prospective registry study.

Atherosclerosis·2010
Same author

Triglycerides and small dense low density lipoprotein in the discrimination of coronary heart disease risk in South Asian populations.

Atherosclerosis·2009

Area of Science:

  • Cardiology
  • Endocrinology
  • Metabolic Disorders

Background:

  • Coronary heart disease is a leading cause of death in diabetic patients with high cholesterol.
  • Diabetes mellitus, both insulin-dependent and non-dependent, is linked to increased very low-density lipoprotein (VLDL) levels.
  • Vascular disease susceptibility in diabetics may stem from elevated intermediate-density lipoproteins (IDL) during VLDL metabolism.

Purpose of the Study:

  • To explore the relationship between diabetes, dyslipidemia, and cardiovascular disease.
  • To evaluate therapeutic strategies for managing lipid profiles and blood pressure in diabetic patients.
  • To clarify the role of various lipoproteins in diabetic cardiovascular complications.

Main Methods:

  • Review of existing literature on diabetes, lipid metabolism, and cardiovascular risk factors.
  • Analysis of the impact of different drug classes (lipid-lowering, antihypertensive) on diabetic patients.
  • Assessment of current evidence regarding hypertension management in the context of diabetes and hyperlipidemia.

Main Results:

  • Elevated VLDL and IDL are characteristic of diabetic dyslipidemia and contribute to cardiovascular risk.
  • Weight reduction is crucial for improving insulin resistance in non-insulin-dependent diabetes.
  • Fibrates are effective lipid-lowering agents for diabetics, while thiazides and beta-blockers can negatively impact lipid profiles.

Conclusions:

  • Comprehensive cardiovascular risk assessment is essential for diabetic patients, mirroring that of non-diabetic individuals.
  • Antihypertensive therapy decisions should consider the overall patient risk profile, not just blood pressure readings.
  • Agents that do not adversely affect lipid profiles are preferred for hypertensive diabetic patients, especially those with hyperlipidemia.

Related Experiment Videos